Equities

National Research Corp

National Research Corp

Actions
Health CareHealth Care Providers
  • Price (USD)19.74
  • Today's Change0.618 / 3.23%
  • Shares traded19.59k
  • 1 Year change-52.48%
  • Beta0.5160
Data delayed at least 15 minutes, as of Nov 25 2024 16:37 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year National Research Corp had little change in net income (from 31.80m to 30.97m). Revenues were also little changed (from 151.57m to 148.58m.)
Gross margin60.89%
Net profit margin18.79%
Operating margin25.88%
Return on assets21.50%
Return on equity58.54%
Return on investment32.46%
More ▼

Cash flow in USDView more

In 2023, cash reserves at National Research Corp fell by 18.37m. However, the company earned 38.11m from its operations for a Cash Flow Margin of 25.65%. In addition the company used 15.78m on investing activities and also paid 40.71m in financing cash flows.
Cash flow per share1.37
Price/Cash flow per share13.60
Book value per share1.47
Tangible book value per share-1.46
More ▼

Balance sheet in USDView more

National Research Corp has a Debt to Total Capital ratio of 60.77%, a higher figure than the previous year's 24.48%.
Current ratio0.4675
Quick ratio--
Total debt/total equity1.55
Total debt/total capital0.6077
More ▼

Growth rates in USD

Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -42.86% and -1.09%, respectively. Additionally when measured on a five year annualized basis, dividend per share growth is below the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)1.25%
Div growth rate (5 year)-5.29%
Payout ratio (TTM)42.30%
EPS growth(5 years)3.30
EPS (TTM) vs
TTM 1 year ago
-3.37
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.